Literature DB >> 10998656

Assessment of differential gene expression patterns in human colon cancers.

A Hernandez1, F Smith, Q Wang, X Wang, B M Evers.   

Abstract

OBJECTIVE: To use a novel genomic approach to determine differential gene expression patterns in colon cancers of different metastatic potential. SUMMARY BACKGROUND DATA: Colorectal cancer is the third leading cause of cancer deaths in the United States; despite aggressive treatment strategies, the 5-year survival rate for metastatic cancer has not changed in 50 years. The analysis of changes in gene expression patterns associated with metastasis may provide new treatment strategies.
METHODS: Human colon cancer cells KM12C (derived from a Dukes B colon cancer), KML4A (a metastatic variant derived from KM12C), and KM20 (derived from a Dukes D colon cancer) were extracted for RNA. In addition, RNA was extracted from normal colon, primary cancer, and liver metastasis in a patient with metastatic colon cancer. Gene expression patterns for approximately 1,200 human genes were analyzed and compared by cDNA array techniques.
RESULTS: Of the roughly 1,200 genes assessed in the KM cell lines, 9 genes were noted to have a more than threefold change in expression (either increased or decreased) in the more metastatic KML4A and KM20 cells compared with KM12C. Assessment of tissues from a patient with metastatic colon cancer demonstrated a more than threefold change in the expression of 14 genes in the primary cancer and liver metastasis compared with normal mucosa.
CONCLUSIONS: Using cDNA expression array technology, the authors identified genes with expression levels that are altered with metastasis. The ability to analyze and compare the expression patterns of multiple genes simultaneously provides a powerful technique to identify potential molecular targets for novel therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10998656      PMCID: PMC1421190          DOI: 10.1097/00000658-200010000-00013

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  36 in total

1.  The plakophilin 1 (PKP1) and plakoglobin (JUP) genes map to human chromosomes 1q and 17, respectively.

Authors:  C M Cowley; D Simrak; N K Spurr; J Arnemann; R S Buxton
Journal:  Hum Genet       Date:  1997-09       Impact factor: 4.132

2.  Induction of cyclooxygenase-2 by the activated MEKK1 --> SEK1/MKK4 --> p38 mitogen-activated protein kinase pathway.

Authors:  Z Guan; S Y Buckman; A P Pentland; D J Templeton; A R Morrison
Journal:  J Biol Chem       Date:  1998-05-22       Impact factor: 5.157

Review 3.  Molecular advances in the etiology and treatment of colorectal cancer.

Authors:  B A Bradley; B M Evers
Journal:  Surg Oncol       Date:  1997-11       Impact factor: 3.279

Review 4.  Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back.

Authors:  P R Walker; P Saas; P Y Dietrich
Journal:  J Immunol       Date:  1997-05-15       Impact factor: 5.422

5.  Invasion of the bladder by transitional cell carcinoma: its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, epidermal growth factor receptor, and bcl-2.

Authors:  R T Vollmer; P A Humphrey; P E Swanson; M R Wick; M L Hudson
Journal:  Cancer       Date:  1998-02-15       Impact factor: 6.860

6.  Molecular characterization of human zyxin.

Authors:  T Macalma; J Otte; M E Hensler; S M Bockholt; H A Louis; M Kalff-Suske; K H Grzeschik; D von der Ahe; M C Beckerle
Journal:  J Biol Chem       Date:  1996-12-06       Impact factor: 5.157

7.  Enterocyte-like differentiation of the Caco-2 intestinal cell line is associated with increases in AP-1 protein binding.

Authors:  Q Ding; Z Dong; B M Evers
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

8.  Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.

Authors:  L Rivoltini; M Radrizzani; P Accornero; P Squarcina; C Chiodoni; A Mazzocchi; C Castelli; P Tarsini; V Viggiano; F Belli; M P Colombo; G Parmiani
Journal:  J Immunol       Date:  1998-08-01       Impact factor: 5.422

9.  Protein kinase mutants of human ATR increase sensitivity to UV and ionizing radiation and abrogate cell cycle checkpoint control.

Authors:  J A Wright; K S Keegan; D R Herendeen; N J Bentley; A M Carr; M F Hoekstra; P Concannon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

10.  The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.

Authors:  J O'Connell; G C O'Sullivan; J K Collins; F Shanahan
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

View more
  9 in total

1.  Identification of disease-specific genes in chronic pancreatitis using DNA array technology.

Authors:  H Friess; J Ding; J Kleeff; Q Liao; P O Berberat; J Hammer; M W Büchler
Journal:  Ann Surg       Date:  2001-12       Impact factor: 12.969

2.  cDNA array analysis for prediction of hepatic metastasis of colorectal carcinoma.

Authors:  Osamu Takata; Yutaka J Kawamura; Fumio Konishi; Junichi Sasaki; Toshihiro Kai; Yasuyuki Miyakura; Hideo Nagai; Toshihiko Tsukamoto
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

Review 3.  Carcinoembryonic antigen (CEA) and its receptor hnRNP M are mediators of metastasis and the inflammatory response in the liver.

Authors:  Peter Thomas; R Armour Forse; Olga Bajenova
Journal:  Clin Exp Metastasis       Date:  2011-09-07       Impact factor: 5.150

4.  Cytokine induction of tumor necrosis factor receptor 2 is mediated by STAT3 in colon cancer cells.

Authors:  Kathryn E Hamilton; James G Simmons; Shengli Ding; Laurianne Van Landeghem; P Kay Lund
Journal:  Mol Cancer Res       Date:  2011-10-12       Impact factor: 5.852

Review 5.  DNA array-based gene profiling: from surgical specimen to the molecular portrait of cancer.

Authors:  Simone Mocellin; Maurizio Provenzano; Carlo Riccardo Rossi; Pierluigi Pilati; Donato Nitti; Mario Lise
Journal:  Ann Surg       Date:  2005-01       Impact factor: 12.969

6.  Sensitization of human colon cancer cells to TRAIL-mediated apoptosis.

Authors:  A Hernandez; Q D Wang; S A Schwartz; B M Evers
Journal:  J Gastrointest Surg       Date:  2001 Jan-Feb       Impact factor: 3.267

7.  Expression of mir-21 and mir-143 in cervical specimens ranging from histologically normal through to invasive cervical cancer.

Authors:  Georgios Deftereos; Simon R Corrie; Qinghua Feng; Janice Morihara; Joshua Stern; Stephen E Hawes; Nancy B Kiviat
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

8.  Volasertib Enhances Sensitivity to TRAIL in Renal Carcinoma Caki Cells through Downregulation of c-FLIP Expression.

Authors:  Mi-Yeon Jeon; Kyoung-Jin Min; Seon Min Woo; Seung Un Seo; Shin Kim; Jong-Wook Park; Taeg Kyu Kwon
Journal:  Int J Mol Sci       Date:  2017-11-29       Impact factor: 5.923

9.  Maritoclax Enhances TRAIL-Induced Apoptosis via CHOP-Mediated Upregulation of DR5 and miR-708-Mediated Downregulation of cFLIP.

Authors:  Mi-Yeon Jeon; Kyoung-Jin Min; Seon Min Woo; Seung Un Seo; Yung Hyun Choi; Sang Hyun Kim; Dong Eun Kim; Tae-Jin Lee; Shin Kim; Jong-Wook Park; Taeg Kyu Kwon
Journal:  Molecules       Date:  2018-11-20       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.